Please assess the completion status of the following clinical trial:

Trial Title: Lumbar Plexus vs Quadratus Lumborum Block in Post-operative Pain Following Total Hip Replacement

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Patients 18-90 years old~2. Primary unilateral total hip arthroplasty~3. BMI 20 - 36~4. Male and Female~5. All races~Exclusion Criteria:~1. Patient refusal~2. ASA class \> or = 4~3. Pregnancy~4. Any condition precluding patient going home with in 24 hours of surgery~5. Non-English speaking or inability to participate in the study~6. Patients with coagulopathy or on therapeutic anticoagulation~7. Chronic Steroid Use~8. Narcotic Addiction

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- Lumbar Plexus block (Type: ACTIVE_COMPARATOR): 0.5% ropivacaine 100 mg (20 ml) will be injected
- Quadratus Lumborum type 3 block (Type: EXPERIMENTAL): 0.5% ropivacaine 100 mg (20 ml) will be injected

Based on this trial design, predict the completion outcome and termination type (if applicable).